<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04257773</url>
  </required_header>
  <id_info>
    <org_study_id>CityUHK</org_study_id>
    <nct_id>NCT04257773</nct_id>
  </id_info>
  <brief_title>International REACH Forgiveness Intervention</brief_title>
  <official_title>International REACH Forgiveness Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>City University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>City University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Six sites spanning five regions (Hong Kong, Colombia, Indonesia, Ukraine, South Africa) will
      administer a forgiveness workbook intervention in a randomized design with a stepped,
      waitlist intervention deployment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention deployment:

      ODO1 X O2 O3 (immediate-treatment [IT ] group) ODO1 O2 X O3 (delayed-treatment [DT ] group)

      where OD denotes measurement of baseline demographic and personality measures, X denotes
      deployment of the intervention, and O1, O2, and O3 denote measurements of outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 16, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depression (BSI)</measure>
    <time_frame>4 months</time_frame>
    <description>Brief Symptom Index, minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety (BSI)</measure>
    <time_frame>4 months</time_frame>
    <description>Brief Symptom Index. minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forgiveness (TRIM)</measure>
    <time_frame>4 months</time_frame>
    <description>Transgression-Related Interpersonal Motivations, minimum value = 1, maximum value = 5. The higher the score, the more unforgiving the person is.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trait Forgiveness (TSF)</measure>
    <time_frame>4 months</time_frame>
    <description>Trait Forgiveness Scale, minimum value = 1, maximum value = 5. The higher the whole score, the more forgiveness the person is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forbearance (FS)</measure>
    <time_frame>4 months</time_frame>
    <description>Forbearance Scale, minimum value = 1, maximum value = 6. The higher the score, the higher forbearing the person is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decision to Forgive (DTSF)</measure>
    <time_frame>4 months</time_frame>
    <description>Decision to Forgive Scale, minimum value = 1, maximum value = 5. The higher the score, the higher decisional forgiveness of the subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flourishing</measure>
    <time_frame>4 months</time_frame>
    <description>Flourishing Index, minimum value = 1, maximum value = 10. The higher the score, the higher flourishing of the subject.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3600</enrollment>
  <condition>Mental Health Wellness</condition>
  <arm_group>
    <arm_group_label>Immediate Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive treatment/intervention immediately.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant in this group will receive treatment/intervention 2-week later.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>REACH Forgiveness Workbook Intervention</intervention_name>
    <description>Participants will be asked to complete the REACH Forgiveness Workbook</description>
    <arm_group_label>Delayed Treatment</arm_group_label>
    <arm_group_label>Immediate Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be able to read and comprehend the materials in the workbook

          -  Must be 18 years old or above

          -  Have someone in mind they want to forgive

        Exclusion Criteria:

          -  No
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Man Yee Ho, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>City University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Man Yee Ho, PhD</last_name>
    <phone>(852) 3442 8962</phone>
    <email>my.ho@cityu.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universidad del Sin√∫</name>
      <address>
        <city>Cordoba</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Ortega Bechara</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>City University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr. HO Man Yee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data, which will be used for meta-analysis, reproducibility, and replication purposes, will be disclosed after the embargo period (30 April, 2024).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After the embargo period (30 April, 2024)</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

